Literature DB >> 22028313

X-ray computed tomography imaging of breast cancer by using targeted peptide-labeled bismuth sulfide nanoparticles.

Joseph M Kinsella1, Rebecca E Jimenez, Priya P Karmali, Anthony M Rush, V Ramana Kotamraju, Nathan C Gianneschi, Erkki Ruoslahti, Dwayne Stupack, Michael J Sailor.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22028313      PMCID： PMC3530424          DOI： 10.1002/anie.201104507

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN： 1433-7851            Impact factor:   15.336


× No keyword cloud information.
  29 in total

1.  In vivo imaging of quantum dots encapsulated in phospholipid micelles.

Authors:  Benoit Dubertret; Paris Skourides; David J Norris; Vincent Noireaux; Ali H Brivanlou; Albert Libchaber
Journal:  Science       Date:  2002-11-29       Impact factor: 47.728

Review 2.  Tumour angiogenesis and its relation to contrast enhancement on computed tomography: a review.

Authors:  K A Miles
Journal:  Eur J Radiol       Date:  1999-06       Impact factor: 3.528

3.  Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model.

Authors:  W Arap; R Pasqualini; E Ruoslahti
Journal:  Science       Date:  1998-01-16       Impact factor: 47.728

4.  Tumor imaging by means of proteolytic activation of cell-penetrating peptides.

Authors:  Tao Jiang; Emilia S Olson; Quyen T Nguyen; Melinda Roy; Patricia A Jennings; Roger Y Tsien
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-15       Impact factor: 11.205

5.  Novel receptor-targeted fluorescent contrast agents for in vivo tumor imaging.

Authors:  S Achilefu; R B Dorshow; J E Bugaj; R Rajagopalan
Journal:  Invest Radiol       Date:  2000-08       Impact factor: 6.016

6.  Nanocrystal targeting in vivo.

Authors:  Maria E Akerman; Warren C W Chan; Pirjo Laakkonen; Sangeeta N Bhatia; Erkki Ruoslahti
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-16       Impact factor: 11.205

7.  Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance.

Authors:  L R Hirsch; R J Stafford; J A Bankson; S R Sershen; B Rivera; R E Price; J D Hazle; N J Halas; J L West
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-03       Impact factor: 11.205

Review 8.  Targeting of drugs and nanoparticles to tumors.

Authors:  Erkki Ruoslahti; Sangeeta N Bhatia; Michael J Sailor
Journal:  J Cell Biol       Date:  2010-03-15       Impact factor: 10.539

9.  Antitumor activity of a homing peptide that targets tumor lymphatics and tumor cells.

Authors:  Pirjo Laakkonen; Maria E Akerman; Hector Biliran; Meng Yang; Fernando Ferrer; Terhi Karpanen; Robert M Hoffman; Erkki Ruoslahti
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-14       Impact factor: 11.205

10.  A tumor-homing peptide with a targeting specificity related to lymphatic vessels.

Authors:  Pirjo Laakkonen; Kimmo Porkka; Jason A Hoffman; Erkki Ruoslahti
Journal:  Nat Med       Date:  2002-06-10       Impact factor: 53.440
View more
  37 in total

Review 1.  Vascular targeting of nanoparticles for molecular imaging of diseased endothelium.

Authors:  Prabhani U Atukorale; Gil Covarrubias; Lisa Bauer; Efstathios Karathanasis
Journal:  Adv Drug Deliv Rev       Date:  2016-09-15       Impact factor: 15.470

Review 2.  New Applications of Cardiac Computed Tomography: Dual-Energy, Spectral, and Molecular CT Imaging.

Authors:  Ibrahim Danad; Zahi A Fayad; Martin J Willemink; James K Min
Journal:  JACC Cardiovasc Imaging       Date:  2015-06

3.  In vitro cytotoxicity of surface modified bismuth nanoparticles.

Authors:  Yang Luo; Chaoming Wang; Yong Qiao; Mainul Hossain; Liyuan Ma; Ming Su
Journal:  J Mater Sci Mater Med       Date:  2012-07-17       Impact factor: 3.896

4.  An all-in-one nanoparticle (AION) contrast agent for breast cancer screening with DEM-CT-MRI-NIRF imaging.

Authors:  Jessica C Hsu; Pratap C Naha; Kristen C Lau; Peter Chhour; Renee Hastings; Brianna F Moon; Joel M Stein; Walter R T Witschey; Elizabeth S McDonald; Andrew D A Maidment; David P Cormode
Journal:  Nanoscale       Date:  2018-09-20       Impact factor: 7.790

Review 5.  A Review on the Biodistribution, Pharmacokinetics and Toxicity of Bismuth-Based Nanomaterials.

Authors:  Samireh Badrigilan; Fatemeh Heydarpanahi; Jalal Choupani; Mehdi Jaymand; Hadi Samadian; Mojtaba Hoseini-Ghahfarokhi; Thomas J Webster; Lobat Tayebi
Journal:  Int J Nanomedicine       Date:  2020-09-25

6.  Gold silver alloy nanoparticles (GSAN): an imaging probe for breast cancer screening with dual-energy mammography or computed tomography.

Authors:  Pratap C Naha; Kristen C Lau; Jessica C Hsu; Maryam Hajfathalian; Shaameen Mian; Peter Chhour; Lahari Uppuluri; Elizabeth S McDonald; Andrew D A Maidment; David P Cormode
Journal:  Nanoscale       Date:  2016-07-14       Impact factor: 7.790

7.  Bismuth@US-tubes as a Potential Contrast Agent for X-ray Imaging Applications.

Authors:  Eladio J Rivera; Lesa A Tran; Mayra Hernández-Rivera; Diana Yoon; Antonios G Mikos; Irene A Rusakova; Benjamin Y Cheong; Maria da Graça Cabreira-Hansen; James T Willerson; Emerson C Perin; Lon J Wilson
Journal:  J Mater Chem B       Date:  2013-10-07       Impact factor: 6.331

8.  Dextran coated bismuth-iron oxide nanohybrid contrast agents for computed tomography and magnetic resonance imaging.

Authors:  Pratap C Naha; Ajlan Al Zaki; Elizabeth Hecht; Michael Chorny; Peter Chhour; Eric Blankemeyer; Douglas M Yates; Walter R T Witschey; Harold I Litt; Andrew Tsourkas; David P Cormode
Journal:  J Mater Chem B       Date:  2014-12-14       Impact factor: 6.331

Review 9.  Opportunities for new CT contrast agents to maximize the diagnostic potential of emerging spectral CT technologies.

Authors:  Benjamin M Yeh; Paul F FitzGerald; Peter M Edic; Jack W Lambert; Robert E Colborn; Michael E Marino; Paul M Evans; Jeannette C Roberts; Zhen J Wang; Margaret J Wong; Peter J Bonitatibus
Journal:  Adv Drug Deliv Rev       Date:  2016-09-09       Impact factor: 15.470

10.  Interactions Between Tumor Biology and Targeted Nanoplatforms for Imaging Applications.

Authors:  Mehdi Azizi; Hassan Dianat-Moghadam; Roya Salehi; Masoud Farshbaf; Disha Iyengar; Samaresh Sau; Arun K Iyer; Hadi Valizadeh; Mohammad Mehrmohammadi; Michael R Hamblin
Journal:  Adv Funct Mater       Date:  2020-03-03       Impact factor: 18.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.